BioSpace News Archive

Study achieved primary endpoint demonstrating pharmacokinetic bioequivalence between Captisol-enabled Iohexol and OMNIPAQUE™

Company also announces access to prime B.C. resources via agreement with Naturo Springs

Adding drug collection units in 53 pharmacy store locations across the state to increase community access to safe disposal of unwanted medications

Mr. Mathur has deep expertise in healthcare investing.

Agreement Includes Products, Technology and Manufacturing Assets in Brazil, India & South Africa

Medial EarlySign™ (earlysign.com), a leader in machine learning-based solutions to aid in early detection and prevention of high-burden diseases, today announced it is partnering with Geisinger and its Steele Institute for Health Innovation to develop and deploy a suite of machine learning-based solutions to identify individuals at risk of a range of chronic and high-burden diseases.

With best-in-class technology and award-winning customer service, Rectangle Health works with 50,000-plus healthcare providers in the U.S., reliably processing over $5 billion annually in patient payments.

Bioethics International (BEI), a not-for-profit organization dedicated to raising the bar on ethics, trustworthiness and patient-centricity in the pharmaceutical industry, today announced the third publication of its Good Pharma Scorecard (GPS) in The BMJ

Responding to the growth of the global point-of-care (POC) diagnostics market, which is projected to exceed $38 billion by 2022 (MarketsandMarkets™), Cambridge Healthtech Institute will expand opportunities to explore POC innovations during its eleventh annual Next Generation Dx Summit, taking place August 20-22, 2019 in Washington, DC.

Following a two year-long pilot project, Cloud DX is excited to announce the purchase of several new Connected Health Kits by Markham Stouffville Hospital (MSH) to continue to provide remote monitoring for patients with Chronic Obstructive Pulmonary Disease (COPD).